Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 337 followers
Latest posts
Last updated 32 minutes ago
‘We’re moving quickly’: Startup bags rare disease drug as Thiel-backed CEO eyes $50M fundraise
32 minutes ago
A rare disease startup with a mission to repurpose proven drugs has...
Why Novartis CEO ended his ADC holdout for $1.5B Myricx deal
about 15 hours ago
For years, as Big Pharma poured billions into ADCs, Novartis CEO Vas...
Roche taps Foundation Medicine’s chief as new North America Diagnostics lead, creates new commercial role
about 17 hours ago
Dan Malarek is leaving his role as chief executive of Roche’s sequencing...
Jupiter enters psychedelics space with $100M deal for PharmAla's MDMA drug
about 18 hours ago
Jupiter Neurosciences will pay $3.3 million upfront to Canada's PharmAla Biotech for...
Agios says adios to sickle cell program over lackluster phase 2 data
about 20 hours ago
A phase 2 study of Agios Pharmaceuticals’ next-generation pyruvate kinase activator has...
Indian generics maker Lupin seeds US spinout Kaveri with cash, clinical-phase cancer assets
about 20 hours ago
Lupin has spun out two clinical-phase cancer drug candidates to create Kaveri...
Novartis drops phase 2 radioligand therapy, but CEO’s commitment to modality 'unchanged'
about 21 hours ago
Novartis has dropped a phase 2-stage radioligand therapy after the candidate disappointed...
Genetic medicine luminaries launch new center for personalized therapies
about 21 hours ago
A team of veteran scientists from elite institutions has come together to...
‘There is always a first’: Why US biotech Axiom will begin its IPO journey in Hong Kong
about 22 hours ago
Axiom Biosciences intends to pursue an IPO on the Hong Kong Stock...
Abbott hit by cyberattack on cancer diagnostics, LabCentral portal businesses
1 day ago
Abbott has been struck by several cyberattacks which targeted the medtech giant’s...
BMS expands AI footprint with Nvidia, aiming for ‘most powerful AI factory in life sciences’
2 days ago
Bristol Myers Squibb has entered into an expanded collaboration with Nvidia to...
De-Risking a Rare Disease Launch Starts with Precision
2 days ago
Why traditional models fall short in rare disease commercialization—and what works instead.